1. IPO
Tatva Chintan Pharma Chem Limited

Tatva Chintan Pharma Chem Limited

listed
₹13,949Min. investment
  1. Bid start
    16 Jul
  2. Bid end
    20 Jul
  3. Allotment
    18 Jul
  4. Release of funds
    27 Jul
  5. Demat transfer
    26 Jul
  6. Listing
    29 Jul

Tatva Chintan Pharma Chem Limited IPO Details

Price range₹1,073 – ₹1,083
IPO type
Regular
Lot size13 shares
Issue size₹500Cr

Checklist

Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Established in 1996, Gujarat-based Tatva Chintan Pharma Chem is a specialty chemicals manufacturer with a diverse portfolio of 154 products. The company makes structure directing agents (SDAs), phase transfer catalysts (PTCs), pharmaceutical and agrochemical intermediates. These chemicals are used in various sectors including automotive, petroleum, dyes and pigments, paints and coatings and personal care. Tatva Chintan Pharma is an export-oriented company, with 70% of its total revenue coming from overseas markets, including the US, China and South Africa.The company has reported strong growth over the past three years. Its revenue and net profit have surged at a CAGR of 20.5% and 59.5%, respectively, during FY19–21.

Frequently asked questions

How to invest in the Tatva Chintan Pharma Chem Limited ?

Investors can apply for the Tatva Chintan Pharma Chem Limited through their Demat account via the stock exchange or through their broker.

What is the issue size of Tatva Chintan Pharma Chem Limited ?

The issue size of the Tatva Chintan Pharma Chem Limited is 500 Cr.

What is 'pre-apply' for Tatva Chintan Pharma Chem Limited ?

Pre-applying for an IPO allows you to submit your application before the official subscription period begins.

Which exchanges will Tatva Chintan Pharma Chem Limited shares list on?

The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.